Trials / Completed
CompletedNCT01092351
Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in Adults
Open Label Study on the Bacteriological and Clinical Efficacy and Safety of a Nitrofurantoin Formulation Given Twice Daily (Bid) for Seven Days in Uncomplicated Urinary Tract Infection in Adults
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Mepha Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to investigate bacteriological efficacy of a nitrofurantoin formulation given twice daily for seven days in the treatment of adult patients with microbiologically confirmed uncomplicated urinary tract infection. Additional study objectives are to evaluate clinical efficacy as well as safety and tolerability of the nitrofurantoin formulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitrofurantoin | 100 mg retard capsules to be taken twice daily for seven days |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2010-03-24
- Last updated
- 2010-03-24
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01092351. Inclusion in this directory is not an endorsement.